235 studies found for:    Open Studies | "Hepatitis B"
Show Display Options
Rank Status Study
21 Recruiting A Study to Characterise Immune Responses Following Immunisations With "Fendrix" or "Engerix B" Hepatitis B Vaccines
Condition: Hepatitis B
Interventions: Biological: Engerix B IM injection - 20ug;   Biological: Fendrix IM injection - 20ug
22 Unknown  Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Pegasys plus Entecavir;   Drug: Entecavir
23 Recruiting Maternal Antiviral Prophylaxis to Prevent Perinatal Transmission of Hepatitis B Virus in Thailand
Conditions: Hepatitis B Chronic Infection;   Pregnancy
Interventions: Drug: tenofovir disoproxil fumarate;   Drug: placebo
24 Unknown  Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)
Conditions: Liver Cirrhosis;   Chronic Hepatitis B
Intervention: Drug: telbivudine
25 Recruiting Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: NVR 3-778;   Drug: Placebo for NVR 3-778;   Drug: Pegasys
26 Unknown  Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: PEG-IFN and entecavir
27 Not yet recruiting Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy
Conditions: Lymphoma;   Chronic Hepatitis B
28 Recruiting Safety and Efficacy of GS-9620 for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Subjects
Condition: Chronic Hepatitis B
Interventions: Drug: GS-9620;   Drug: Placebo to match GS-9620
29 Recruiting Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon (Pegasys) (52 weeks);   Drug: Peginterferon (Pegasys) (96 weeks);   Drug: Peginterferon (Pegasys) (48 weeks)
30 Recruiting Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis B
Condition: Hepatitis B, Chronic
Interventions: Drug: Entecavir and peginterferon alfa-2a;   Drug: Placebo and peginterferon
31 Unknown  Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young Adults
Condition: Hepatitis B
32 Recruiting Abatacept vs Placebo in RA Patients With Hepatitis B on Entecavir Background
Conditions: Rheumatoid Arthritis;   Chronic Hepatitis B
Interventions: Drug: Abatacept;   Drug: Placebo
33 Recruiting Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
Conditions: Hepatitis B;   Liver Transplantation
Intervention: Drug: Hepatitis B immune globulin
34 Recruiting Randomized,Paralleled-group Clinical Trial of Hepatitis B Vaccine With Different Doses and Schedules in Healthy Adults
Condition: Hepatitis B
Intervention: Biological: Hepatitis B vaccine
35 Unknown  Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy
Condition: Chronic Hepatitis B
Intervention: Drug: Switching from adefovir (10mg/day) to tenofovir (300mg/day)
36 Recruiting Efficacy of Switching or Adding Pegylated Interferon in Chronic Hepatitis B Patients on Long Term Oral Antiviral Therapy
Condition: Chronic Hepatitis B
Interventions: Drug: peg-interferon alpha 2b, 1.5mcg/kg s/c given weekly;   Drug: Nucleos(t)ide analogue therapy
37 Recruiting Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Tenofovir disoproxil fumarate;   Drug: Lamivudine plus adefovir
38 Recruiting Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Condition: Chronic Hepatitis B
Interventions: Drug: Continue NA treatment;   Drug: Discontinue NA Treatment
39 Not yet recruiting HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance
Condition: Chronic Hepatitis B
Interventions: Drug: PEG-interferon-Alfa-2A;   Drug: Nucleosides
40 Unknown  Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Drug: Tenofovir;   Drug: Telbivudine;   Drug: Tenofovir plus Telbivudine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years